Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Siga Technologies Return on Tangible Equity 2010-2025 | SIGA

Current and historical return on tangible equity values for Siga Technologies (SIGA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Siga Technologies Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.05B $0.22B 25.59%
2024-12-31 $0.06B $0.22B 33.01%
2024-09-30 $0.09B $0.17B 48.85%
2024-06-30 $0.08B $0.17B 51.69%
2024-03-31 $0.08B $0.16B 52.15%
2023-12-31 $0.07B $0.20B 45.11%
2023-09-30 $-0.01B $0.12B -3.47%
2023-06-30 $0.03B $0.12B 17.92%
2023-03-31 $0.03B $0.16B 20.59%
2022-12-31 $0.03B $0.17B 21.02%
2022-09-30 $0.11B $0.17B 66.36%
2022-06-30 $0.07B $0.14B 49.23%
2022-03-31 $0.07B $0.17B 49.82%
2021-12-31 $0.07B $0.17B 53.38%
2021-09-30 $0.02B $0.11B 13.53%
2021-06-30 $0.04B $0.12B 35.91%
2021-03-31 $0.06B $0.12B 56.14%
2020-12-31 $0.06B $0.13B 53.21%
2020-09-30 $0.03B $0.11B 31.88%
2020-06-30 $0.01B $0.09B 6.33%
2020-03-31 $-0.02B $0.09B -18.51%
2019-12-31 $-0.01B $0.10B -6.88%
2019-09-30 $0.05B $0.10B 48.54%
2019-06-30 $0.44B $0.10B 485.08%
2019-03-31 $0.44B $0.11B -2096.39%
2018-12-31 $0.42B $0.10B -321.37%
2018-09-30 $0.36B $0.05B -151.16%
2018-06-30 $-0.04B $-0.34B 11.85%
2018-03-31 $-0.04B $-0.34B 12.52%
2017-12-31 $-0.04B $-0.32B 11.95%
2017-09-30 $-0.04B $-0.31B 12.30%
2017-06-30 $-0.04B $-0.30B 11.97%
2017-03-31 $-0.04B $-0.30B 12.62%
2016-12-31 $-0.04B $-0.29B 12.97%
2016-09-30 $-0.05B $-0.31B 16.33%
2016-06-30 $-0.05B $-0.31B 15.97%
2016-03-31 $-0.04B $-0.30B 15.54%
2015-12-31 $-0.04B $-0.29B 15.02%
2015-09-30 $-0.04B $-0.27B 15.19%
2015-06-30 $-0.27B $-0.26B 110.30%
2015-03-31 $-0.27B $-0.25B 149.65%
2014-12-31 $-0.27B $-0.25B 234.51%
2014-09-30 $-0.25B $-0.23B 529.10%
2014-06-30 $-0.02B $0.01B -103.45%
2014-03-31 $-0.02B $0.01B -85.71%
2013-12-31 $-0.02B $0.02B -82.93%
2013-09-30 $-0.02B $0.02B -68.82%
2013-06-30 $-0.01B $0.02B -52.83%
2013-03-31 $-0.02B $0.03B -51.72%
2012-12-31 $-0.02B $0.03B -46.88%
2012-09-30 $0.00B $0.03B -5.67%
2012-06-30 $0.00B $0.03B 2.58%
2012-03-31 $0.03B $0.04B 70.73%
2011-12-31 $0.03B $0.04B 84.67%
2011-09-30 $-0.02B $0.05B -62.96%
2011-06-30 $-0.02B $0.04B -120.00%
2011-03-31 $-0.05B $0.01B -645.16%
2010-12-31 $-0.05B $0.01B -714.29%
2010-09-30 $-0.02B $0.01B -260.87%
2010-06-30 $-0.01B $0.00B -1200.00%
2010-03-31 $-0.02B $0.01B 523.08%
2009-12-31 $-0.02B $0.01B 281.48%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.629B $0.139B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $69.309B 26.66
Zoetis (ZTS) United States $67.559B 24.51
Takeda Pharmaceutical (TAK) Japan $46.997B 9.59
Daiichi Sankyo, - (DSNKY) Japan $46.127B 23.64
BeOne Medicines - (ONC) Switzerland $33.703B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.121B 0.00
Summit Therapeutics (SMMT) United States $19.960B 0.00
Merck (MKKGY) Germany $16.834B 10.94
Shionogi (SGIOY) Japan $15.517B 15.55
United Therapeutics (UTHR) United States $13.970B 12.09
Neurocrine Biosciences (NBIX) United States $13.054B 38.94
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.601B 0.00
Madrigal Pharmaceuticals (MDGL) United States $8.292B 0.00
Corcept Therapeutics (CORT) United States $7.671B 64.43
Grifols, S.A (GRFS) Spain $7.316B 0.00
Ionis Pharmaceuticals (IONS) United States $6.870B 0.00
Stevanato Group S.p.A (STVN) Italy $6.772B 39.93
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.312B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.946B 14.03
NewAmsterdam Pharma (NAMS) Netherlands $2.892B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.834B 0.00
Hypermarcas (HYPMY) Brazil $2.665B 20.04
Catalyst Pharmaceuticals (CPRX) United States $2.471B 8.27
Centessa Pharmaceuticals (CNTA) United Kingdom $2.298B 0.00
Ocular Therapeutix (OCUL) United States $2.175B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.791B 0.00
Dyne Therapeutics (DYN) United States $1.741B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.581B 23.55
ARS Pharmaceuticals (SPRY) United States $1.554B 0.00
Guardian Pharmacy Services (GRDN) United States $1.490B 0.00
Ardelyx (ARDX) United States $1.386B 0.00
Evotec AG (EVO) Germany $1.353B 0.00
Harrow (HROW) United States $1.351B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.332B 0.00
Collegium Pharmaceutical (COLL) United States $1.193B 6.52
Xeris Biopharma Holdings (XERS) United States $1.176B 0.00
Cronos Group (CRON) Canada $1.006B 0.00
Enliven Therapeutics (ELVN) United States $0.981B 0.00
Akebia Therapeutics (AKBA) United States $0.875B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.740B 0.00
ProKidney (PROK) United States $0.694B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.656B 6.76
KalVista Pharmaceuticals (KALV) United States $0.629B 0.00
Organogenesis (ORGO) United States $0.623B 0.00
Theravance Biopharma (TBPH) United States $0.621B 51.75
Bioventus (BVS) United States $0.619B 15.06
Relay Therapeutics (RLAY) United States $0.590B 0.00
Oruka Therapeutics (ORKA) United States $0.574B 0.00
USANA Health Sciences (USNA) United States $0.572B 11.72
Tourmaline Bio (TRML) United States $0.571B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
Xencor (XNCR) United States $0.551B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.540B 0.00
Zevra Therapeutics (ZVRA) United States $0.529B 0.00
Savara (SVRA) United States $0.467B 0.00
Aquestive Therapeutics (AQST) United States $0.400B 0.00
Esperion Therapeutics (ESPR) United States $0.385B 0.00
Nanobiotix S.A (NBTX) France $0.376B 0.00
Altimmune (ALT) United States $0.330B 0.00
Aldeyra Therapeutics (ALDX) United States $0.322B 0.00
Nektar Therapeutics (NKTR) United States $0.319B 0.00
4D Molecular Therapeutics (FDMT) United States $0.312B 0.00
Larimar Therapeutics (LRMR) United States $0.308B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 19.26
AleAnna (ANNA) United States $0.287B 0.00
OmniAb (OABI) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.232B 0.00
Heron Therapeutics (HRTX) United States $0.215B 0.00
Lyell Immunopharma (LYEL) United States $0.208B 0.00
MediWound (MDWD) Israel $0.203B 0.00
China SXT Pharmaceuticals (SXTC) China $0.187B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
Korro Bio (KRRO) United States $0.178B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.176B 27.25
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.169B 0.00
MEI Pharma (MEIP) United States $0.166B 0.00
Profound Medical (PROF) Canada $0.164B 0.00
Lexeo Therapeutics (LXEO) United States $0.157B 0.00
Avita Medical (RCEL) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.126B 0.00
Avalo Therapeutics (AVTX) United States $0.119B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.118B 0.00
Liminatus Pharma (LIMN) United States $0.114B 0.00
Cassava Sciences (SAVA) United States $0.110B 0.00
Dominari Holdings (DOMH) United States $0.101B 0.00
Champions Oncology (CSBR) United States $0.094B 21.38
Cardiol Therapeutics (CRDL) Canada $0.092B 0.00
BioNxt Solutions (BNXTF) Canada $0.089B 0.00
Achieve Life Sciences (ACHV) Canada $0.088B 0.00
Surrozen (SRZN) United States $0.086B 0.00
ESSA Pharma (EPIX) Canada $0.085B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
PMV Pharmaceuticals (PMVP) United States $0.081B 0.00
Assertio Holdings (ASRT) United States $0.078B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Nutriband (NTRB) United States $0.074B 0.00
Metagenomi (MGX) United States $0.073B 0.00
Inotiv (NOTV) United States $0.068B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.062B 0.00
DURECT (DRRX) United States $0.059B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Wellgistics Health (WGRX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.051B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.044B 26.64
NRx Pharmaceuticals (NRXP) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.041B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Jupiter Neurosciences (JUNS) United States $0.041B 0.00
FibroGen (FGEN) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Enlivex Therapeutics (ENLV) Israel $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
Scienture Holdings (SCNX) United States $0.036B 0.00
Plus Therapeutics (PSTV) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.033B 0.00
Mural Oncology (MURA) Ireland $0.031B 0.00
Vivos Therapeutics (VVOS) United States $0.027B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Relmada Therapeutics (RLMD) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
Ainos (AIMD) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.90
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00